BNP PARIBAS ASSET MANAGEMENT Holding S.A. lifted its stake in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 100.6% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 141,293 shares of the medical device company’s stock after purchasing an additional 70,867 […]
Korea Investment CORP lessened its stake in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 20.7% in the third quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 458,082 shares of the medical device company’s stock after selling 119,232 shares during the quarter. Korea Investment CORP […]
StockNews.com upgraded shares of DexCom (NASDAQ:DXCM – Free Report) from a hold rating to a buy rating in a research report report published on Monday. A number of other analysts have also recently commented on the stock. Wells Fargo & Company increased their price target on shares of DexCom from $110.00 to $136.00 and gave […]
Rhumbline Advisers lifted its stake in DexCom, Inc. (NASDAQ:DXCM – Free Report) by 0.0% in the third quarter, Holdings Channel.com reports. The firm owned 789,255 shares of the medical device company’s stock after acquiring an additional 133 shares during the quarter. Rhumbline Advisers’ holdings in DexCom were worth $73,637,000 as of its most recent SEC […]
Broadleaf Partners LLC grew its position in shares of DexCom, Inc. (NASDAQ:DXCM – Free Report) by 41.6% during the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 83,912 shares of the medical device company’s stock after buying an additional 24,642 shares during the quarter. […]